These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33741347)

  • 1. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
    Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
    Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
    [No Abstract]   [Full Text] [Related]  

  • 5. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
    Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
    Feng JY; Chen L; Ma YY; Yang HW; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.
    Yadav R; Sharma MC; Malgulwar PB; Pathak P; Sigamani E; Suri V; Sarkar C; Kumar A; Singh M; Sharma BS; Garg A; Bakhshi S; Faruq M
    Neuro Oncol; 2014 Mar; 16(3):372-81. PubMed ID: 24305715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features.
    Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
    Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
    Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
    Oakley GJ; Fuhrer K; Seethala RR
    Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.